Eyepoint Pharmaceuticals Inc Share Price

NASDAQ: EYPT

Small Cap

$13.61

+0.20

(+1.45%)

as on September 17, 2025 at 1:29 am IST

$₹

Eyepoint Pharmaceuticals Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$13.24
Day's Price Range
$13.91
$13.61
2.72%
Downside
2.20%
Upside
52 Week's Low
52 Week's High
$3.91
52-Week Price Range
$14.42
$13.61
71.27%
Downside
5.95%
Upside

Eyepoint Pharmaceuticals Inc share price movements today

Previous Close: $13.41
Open: $13.37
Volume: 751.4K
Day's Low - High: $13.24 - $13.91
52 Week Low - High: $3.91 - $14.42

Eyepoint Pharmaceuticals Inc Historical Returns

1 Month Return: + 20.92 %
3 Month Return: + 50.67 %
1 Year Return: + 51.7 %
3 Year Return: + 64.14 %
5 Year Return: + 148.79 %

Eyepoint Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Eyepoint Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$924.3M

EPS (TTM)

-3.0271

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-187.1M

Revenue (TTM)

51.9M

Profit Margin

0.00%

Return On Equity TTM

0.00%

Eyepoint Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eyepoint Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Eyepoint Pharmaceuticals Inc	BUY	$924.3M	148.79%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Eyepoint Pharmaceuticals Inc Stock including INR - Dollar returns

The Eyepoint Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Eyepoint Pharmaceuticals Inc investment value today

Current value as on today

₹1,58,827

Returns

₹58,827

(+58.83%)

Returns from Eyepoint Pharmaceuticals Inc Stock

₹53,959 (+53.96%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Eyepoint Pharmaceuticals Inc Stock

Based on 16 analysts

BUY

93.75%

Buy

6.25%

Hold

0.00%

Sell

Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Eyepoint Pharmaceuticals Inc. Average target price of $34.42

Eyepoint Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Eyepoint Pharmaceuticals Inc.

What analysts predicted

60.46%UPSIDE

Target Price

$34.42

Current Price

$13.61

Analyzed by

16 Analysts

Target

$34.42

Eyepoint Pharmaceuticals Inc target price $34.42, a slight upside of 60.46% compared to current price of $13.61. According to 16 analysts rating.

Eyepoint Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Eyepoint Pharmaceuticals Inc Stock has increased by 31% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:31% versus previous 30 day period

Eyepoint Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	7	9	15	14	11	9	10	11	24	5
Gross Profit	7	7	14	13	10	8	9	10	23	5
Operating Income	-21	-22	-14	-16	-33	-34	-32	-45	-48	-62
EBITDA	-20	-22	-12	-13	-28	-30	-28	-40	-48	-59
Interest Expense	0	0	-	-	-	-	-	0	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-21	-22	-12	-14	-29	-30	-29	-41	-45	-59
Income Tax Expense	0	-1	1	0	0	-	-	0	-	-
Net Income	-21	-22	-12	-14	-29	-30	-29	-41	-45	-59
Net Profit Margin	-280.96%	-251.73%	-82.96%	-100.51%	-250.63%	-325.27%	-278.99%	-357.26%	-184.82%	-1114.31%

Eyepoint Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	26	1	7	2	20	34	36	41	46	43
Gross Profit	26	1	7	-15	17	28	28	33	41	39
Operating Income	6	-21	-18	-26	-47	-37	-55	-78	-75	-145
EBITDA	7	-20	-17	-36	-48	-35	-50	-96	-69	-129
Interest Expense	-	-	0	0	6	7	5	3	1	0
Depreciation	-	0	1	-	2	2	2	2	0	1
Income Before Tax	6	-21	-18	-53	-56	-45	-58	-102	-70	-130
Income Tax Expense	0	0	0	-25	6	7	5	22	0	0
Net Income	6	-21	-18	-53	-62	-52	-63	-124	-70	-130
Net Profit Margin	23.89%	-1330.06%	-245.19%	-1795.71%	-309.20%	-152.89%	-173.03%	-300.72%	-153.84%	-302.43%

Eyepoint Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-22	-12	-14	-29	-30	-29	-41	-45	-59
Operating Cash Flow	57	-15	-23	-31	-20	-39	-35	-53	-62
Investing Cash Flow	13	-1	-47	20	-160	16	-95	39	-
Financing Cash Flow	-36	10	218	0	0	11	151	0	0
Change in Cash	33	-6	148	-10	-180	-10	19	-14	-14

Eyepoint Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-21	-18	-53	-56	-45	-58	-102	-70	-130
Operating Cash Flow	-16	-20	-21	-56	-14	-50	-65	1	-126
Investing Cash Flow	-4	13	-16	0	0	-33	-17	-3	-219
Financing Cash Flow	16	8	60	33	37	216	0	187	164
Change in Cash	-3	1	21	-23	22	133	-82	185	-181

Global Institutional Holdings in Eyepoint Pharmaceuticals Inc

Funds	Holdings
Cormorant Asset Management, LLC	12.08%
Suvretta Capital Management, LLC	9.87%
Adage Capital Partners Gp LLC	8.99%
BlackRock Inc	8.3%
Franklin Resources Inc	6.02%

See all

Insights on Eyepoint Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, EYPT stock has moved up by 20.9%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 47.4%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.2% return, outperforming this stock by 15.5%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 24.45M → 5.33M (in $), with an average decrease of 78.2% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, -29.36M → -59.42M (in $), with an average decrease of 27.2% per quarter

About Eyepoint Pharmaceuticals Inc

psivida corp., (nasdaq: psdv) (asx: pva) headquartered in watertown, ma, develops tiny, sustained release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. psivida is currently focused on treatment of chronic diseases of the back of the eye utilizing its core technology systems, durasert™ and biosilicon™. the injectable, sustained release micro-insert iluvien® for the treatment of chronic diabetic macula edema (dme), licensed to alimera sciences, inc., has received marketing authorization in austria, france, germany, portugal, the u.k. spain, and italy. iluvien for dme has recently been approved in the us. psivida plans to institute pivotal phase iii clinical trials for the treatment of posterior uveitis with the same micro-insert as iluvien for dme. an investigator-sponsored clinical trial is ongoing for an injectable, bioerodible micro-insert to treat glaucoma and ocular hypertension. psivida's two fda-approved products, retisert®

Organisation	Eyepoint Pharmaceuticals Inc
Headquarters	480 Pleasant Street, Watertown, MA, United States, 02472
Industry	Health Technology
CEO	Dr. Jay S. Duker M.D.
E-voting on shares	Click here to vote

Key Management of Eyepoint Pharmaceuticals Inc

Name	Title
Dr. Marcia Sellos-Moura Ph.D.	Chief Scientific Officer
Mr. Ron I. Honig Esq.	Chief Legal Officer & Company Secretary
Ms. Jennifer Leonard	Chief People Officer & Senior VP of IT
Mr. David Scott Jones M.A.	Senior VP & Chief Commercial Officer
Ms. Isabelle Lefebvre	Chief Regulatory Officer
Dr. Jay S. Duker M.D.	President, CEO & Director
Mr. George O. Elston CPA	Executive VP & CFO
Dr. Ramiro Ribeiro M.D., Ph.D.	Chief Medical Officer
Mr. Michael J. Maciocio	Chief Manufacturing Officer
Dr. Anna Kluczewska	CEO of AION Diagnostics Ltd, President of AION Diagnostics Ltd and Director of AION Diagnostics Ltd

FAQs

What is Eyepoint Pharmaceuticals Inc share price today?

Eyepoint Pharmaceuticals Inc share price today is $13.61 as on September 17, 2025 at 1:29 am IST at the close of the market. Eyepoint Pharmaceuticals Inc share today touched a day high of $13.91 and a low of $13.24.

What is the 52 week high and 52 week low for Eyepoint Pharmaceuticals Inc share?

Eyepoint Pharmaceuticals Inc share touched a 52 week high of $14.42 on September 9, 2025 and a 52 week low of $3.91 on April 9, 2025. Eyepoint Pharmaceuticals Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $13.61,which is 5.62% down from its 52 week high and 248.08% up from its 52 week low.

What is Eyepoint Pharmaceuticals Inc's market capitalisation today?

Eyepoint Pharmaceuticals Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Eyepoint Pharmaceuticals Inc Stock (EYPT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Eyepoint Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eyepoint Pharmaceuticals Inc Shares that will get you 0.1102 shares as per Eyepoint Pharmaceuticals Inc share price of $13.61 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Eyepoint Pharmaceuticals Inc Stock (EYPT) from India?

Indian investors can start investing in Eyepoint Pharmaceuticals Inc (EYPT) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 8:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Eyepoint Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 8:39 am IST). Based on Eyepoint Pharmaceuticals Inc share’s latest price of $13.61 as on September 17, 2025 at 1:29 am IST, you will get 0.7348 shares of Eyepoint Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Eyepoint Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Eyepoint Pharmaceuticals Inc stock has given 148.79% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?